About 60mg Daklinza Daclatasvir Tablet
| Dose/Strength |
60 mg |
| Packaging Size |
28 Tablets |
| Form |
Tablet |
| Brand |
MyDekla |
| Manufacturer |
Glenmark Pharmaceuticals |
| Package Type |
Bottle |
| Treatment |
Chronic hepatitis C |
Mydekla 60 Tablet is an antiviral medication. It is used along with other medications for the treatment of chronic hepatitis C virus (HCV) infection.
Mydekla 60 Tablet should be taken in the dose and duration as advised by your doctor. It should be taken with or without food, preferably at a fixed time. Do not skip any doses and finish the full course of treatment even if you feel better If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
It has fewer side effects as compared to other similar medicines, like fatigue, headache, nausea, insomnia (difficulty sleeping), and anemia (low red blood cell count). Inform your doctor if these side effects persist for a longer duration. Please consult your doctor if you are pregnant, planning to conceive, or breastfeeding.
Powerful Antiviral TherapyDaklinza 60mg is designed to effectively combat chronic Hepatitis C infection by targeting the virus's replication process. Used in combination with other antiviral agents, it helps to significantly reduce the viral load in the body, improving the chances of a sustained virological response. This makes it a valuable addition to current Hepatitis C treatment protocols.
Simple Oral DosageThe convenience of Daklinza comes from its easy-to-administer oral tablet form. With a once-daily dosing schedule, patients can maintain their treatment with minimal disruption to their daily routines. The film-coated, round tablets can be taken with or without food, ensuring flexible integration into existing medication schedules.
Trusted Manufacturing and PackagingManufactured and marketed by Bristol-Myers Squibb in India, Daklinza is supplied in protective blister packaging to ensure each tablet remains effective until use. With a shelf life of 24 months from the date of manufacture and strict storage requirements, the product retains its potency for the duration of the prescribed therapy.
FAQ's of 60mg Daklinza Daclatasvir Tablet:
Q: How should Daklinza 60mg tablets be taken for Hepatitis C treatment?
A: Daklinza 60mg should be taken orally once daily, exactly as prescribed by your physician. It can be taken with or without food and is usually part of combination therapy with other antiviral medications.
Q: What are the uses and benefits of Daklinza 60mg in Hepatitis C management?
A: Daklinza is used to treat chronic Hepatitis C infection in adults. Its main benefit is its ability to block the replication of the virus, leading to a reduction in viral load and improving the likelihood of a sustained cure when used with other antiviral medicines.
Q: When should Daklinza not be taken?
A: Daklinza should only be taken under the supervision of a registered medical practitioner. It is not suitable for individuals allergic to daclatasvir or its ingredients, or those for whom it hasn't been prescribed. Always inform your doctor of your medical history and any other medications you're taking.
Q: Where should Daklinza 60mg tablets be stored?
A: Store Daklinza tablets below 30C in a dry place, and protect them from direct light. Keep the medication in its original blister packaging to preserve its effectiveness until consumption.
Q: What is the process for obtaining Daklinza 60mg tablets?
A: Daklinza is a prescription-only medication. The product can be obtained from licensed pharmacies upon presentation of a valid prescription from a registered medical practitioner.
Q: Is Daklinza suitable for all patients with Hepatitis C?
A: Daklinza 60mg is recommended for adults and should be used strictly in accordance with your doctor's instructions. It is used in combination with other treatments and may not be suitable for every type of Hepatitis C or coexisting medical conditions, so professional guidance is crucial.